SBIR/STTR Research Award

SBIR Phase I: Automatic Design and Optimization of Novel Drug Candidates

Award identifier f68537843ec2244974178b4089cdacae0dc57f1f7e1ebe187c26a2778276afcaAwarding agency National Science Foundation

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
Teraffinity, Inc.
Proposal award date
2014-07-01
Contract end date
2015-06-30
UEI
Not reported
Solicitation number
Not reported
Topic code
BT

Research abstract

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to provide a tool for designing new drugs. Designing new drugs that bind to a specified protein target required finding the best molecule in a vast chemical space. The proposed design tool can search this large chemical space much more efficiently and cheaply compared to current methods. It is based on a "reverse engineering" method to solve the problem of going from a set of desired properties back to chemical structures that may have these properties. This design tool allows the efficient search of the database to find the best molecule in advance of laboratory work. The envisioned technology is expected to shorten the screening and drug discovery phase from 3 years to 1 year, while saving ~$20 M per target overall, by shifting current practices and enabling a rapid, lower cost, and more novel targeted drug discovery and lead identification. This project proposes to develop a computational drug discovery platform. This platform uses advanced QM/MM (quantum chemistry and molecular chemistry combined) calculations for binding accuracy combined with an artificial intelligence heuristic search algorithm to find the most appropriate molecule in a vast molecular space. The advances to be accomplished with this SBIR project include adding two novel toolsl to improve the performance of the current "in silico" drug design algorithm: 1) a multi-object optimization algorithm to further improve high accuracy, and 2) an automated scaffold design algorithm. These will result in highly selective designs with novel scaffolds that not only bind well to the target, but that also have excellent drug-like properties such as low probability of toxicity and off target effects, as well as greater stability and synthesizability. These advancements should provide higher accuracy of binding affinity prediction results with fewer false positives and better molecule selection, and reduced labor, which allows for greater automation.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.